European Association of Nuclear Medicine (EANM) response to the proposed ASTRO's framework for radiopharmaceutical therapy curriculum development for trainees
Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):1-3.
doi: 10.1007/s00259-022-06011-4.
1 Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
2 Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
3 Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Belgium and GIGA-CRC In Vivo Imaging, University of Liège, Liège, Belgium.
4 Department of Nuclear Medicine, University Würzburg, Würzburg, Germany.
5 Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
6 Center for Biomarker Research in Medicine (CBmed GmbH), Graz, Austria.
7 Nuclear Medicine Department, Medical University of Warsaw, ul. Banacha 1 a, 02-097, Warsaw, Poland. jolanta.kunikowska@wum.edu.pl.